Maryam Azimi Mohammadabadi, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Exosomes | 5 | 2023 | 423 | 1.460 |
Why?
|
Aquaporins | 1 | 2024 | 174 | 0.880 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2019 | 556 | 0.860 |
Why?
|
T-Lymphocytes, Regulatory | 6 | 2022 | 3076 | 0.790 |
Why?
|
T-Lymphocyte Subsets | 3 | 2021 | 1811 | 0.760 |
Why?
|
Artemisinins | 2 | 2013 | 218 | 0.750 |
Why?
|
Colorectal Neoplasms | 3 | 2024 | 6855 | 0.650 |
Why?
|
Nucleic Acids | 1 | 2021 | 188 | 0.640 |
Why?
|
Multiple Sclerosis | 4 | 2022 | 3202 | 0.630 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2013 | 501 | 0.520 |
Why?
|
Mesenchymal Stem Cells | 2 | 2022 | 1634 | 0.480 |
Why?
|
Neovascularization, Pathologic | 1 | 2024 | 2641 | 0.450 |
Why?
|
Neoplasm Metastasis | 1 | 2024 | 4891 | 0.440 |
Why?
|
Mammary Glands, Animal | 2 | 2013 | 265 | 0.430 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 3 | 2018 | 305 | 0.400 |
Why?
|
Immunologic Factors | 3 | 2015 | 1589 | 0.400 |
Why?
|
Phytotherapy | 1 | 2013 | 295 | 0.380 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2015 | 664 | 0.370 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2024 | 5230 | 0.330 |
Why?
|
Leukocytes, Mononuclear | 3 | 2020 | 1828 | 0.290 |
Why?
|
Antimalarials | 1 | 2013 | 907 | 0.260 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2013 | 1094 | 0.250 |
Why?
|
Immunotherapy | 2 | 2022 | 4637 | 0.250 |
Why?
|
T-Lymphocytes | 2 | 2019 | 10183 | 0.230 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2250 | 0.220 |
Why?
|
Cell Proliferation | 6 | 2024 | 10434 | 0.210 |
Why?
|
Aquaporin 5 | 1 | 2022 | 8 | 0.210 |
Why?
|
MicroRNAs | 1 | 2019 | 3784 | 0.210 |
Why?
|
Lactobacillus acidophilus | 1 | 2012 | 21 | 0.210 |
Why?
|
Metals, Heavy | 1 | 2023 | 150 | 0.200 |
Why?
|
Galectin 3 | 1 | 2024 | 240 | 0.200 |
Why?
|
Forkhead Transcription Factors | 3 | 2021 | 1613 | 0.200 |
Why?
|
Culture Media, Conditioned | 1 | 2022 | 522 | 0.190 |
Why?
|
Tumor Burden | 3 | 2013 | 1897 | 0.180 |
Why?
|
Curcumin | 1 | 2021 | 98 | 0.170 |
Why?
|
Mice, Inbred BALB C | 4 | 2021 | 6226 | 0.170 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2024 | 475 | 0.170 |
Why?
|
Umbilical Cord | 1 | 2020 | 181 | 0.170 |
Why?
|
Spleen | 2 | 2021 | 2298 | 0.160 |
Why?
|
Blood Proteins | 1 | 2024 | 1172 | 0.160 |
Why?
|
Probiotics | 1 | 2012 | 377 | 0.150 |
Why?
|
Interferon Type I | 1 | 2022 | 559 | 0.150 |
Why?
|
Metal Nanoparticles | 1 | 2022 | 401 | 0.150 |
Why?
|
Immunoassay | 2 | 2016 | 748 | 0.140 |
Why?
|
Receptors, Calcitriol | 1 | 2019 | 359 | 0.140 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2022 | 825 | 0.140 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2021 | 2160 | 0.140 |
Why?
|
Drugs, Investigational | 1 | 2018 | 214 | 0.130 |
Why?
|
Anti-Infective Agents | 1 | 2023 | 982 | 0.130 |
Why?
|
Uterine Neoplasms | 1 | 2024 | 1434 | 0.120 |
Why?
|
Toll-Like Receptor 9 | 1 | 2016 | 235 | 0.120 |
Why?
|
Photochemotherapy | 1 | 2021 | 819 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1791 | 0.120 |
Why?
|
Drug Contamination | 1 | 2015 | 152 | 0.120 |
Why?
|
Coculture Techniques | 1 | 2018 | 1340 | 0.120 |
Why?
|
Myelin Sheath | 1 | 2018 | 651 | 0.120 |
Why?
|
Cell Line, Tumor | 3 | 2024 | 16905 | 0.120 |
Why?
|
Immunomodulation | 1 | 2018 | 547 | 0.120 |
Why?
|
Artemisia annua | 1 | 2013 | 1 | 0.110 |
Why?
|
Gene Expression | 2 | 2024 | 7592 | 0.110 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2018 | 498 | 0.110 |
Why?
|
Cell Growth Processes | 1 | 2013 | 384 | 0.100 |
Why?
|
Molecular Targeted Therapy | 1 | 2024 | 2805 | 0.100 |
Why?
|
Injections, Intralesional | 1 | 2013 | 278 | 0.100 |
Why?
|
Humans | 21 | 2024 | 760261 | 0.100 |
Why?
|
Immune Tolerance | 2 | 2022 | 2299 | 0.100 |
Why?
|
Breast Neoplasms | 2 | 2013 | 21065 | 0.100 |
Why?
|
Cytokines | 4 | 2022 | 7345 | 0.090 |
Why?
|
Bone Marrow Transplantation | 1 | 2018 | 2696 | 0.090 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 13629 | 0.090 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2013 | 1351 | 0.080 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 2014 | 0.080 |
Why?
|
Air Pollutants | 1 | 2023 | 2843 | 0.080 |
Why?
|
Nanoparticles | 1 | 2021 | 1938 | 0.080 |
Why?
|
Animals | 9 | 2024 | 167940 | 0.080 |
Why?
|
Th17 Cells | 1 | 2015 | 789 | 0.080 |
Why?
|
Interleukin-4 | 1 | 2013 | 1133 | 0.080 |
Why?
|
Cells, Cultured | 3 | 2020 | 18968 | 0.080 |
Why?
|
Cell Survival | 1 | 2018 | 5796 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 2015 | 1956 | 0.070 |
Why?
|
Immunosuppressive Agents | 2 | 2022 | 4168 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2022 | 12762 | 0.070 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2018 | 1459 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2022 | 3763 | 0.070 |
Why?
|
Mice | 6 | 2024 | 81216 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3758 | 0.060 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 4900 | 0.060 |
Why?
|
Interferon-gamma | 1 | 2013 | 3160 | 0.060 |
Why?
|
Female | 11 | 2024 | 391011 | 0.060 |
Why?
|
Periodontal Ligament | 1 | 2023 | 117 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2015 | 4355 | 0.050 |
Why?
|
Middle East | 1 | 2023 | 230 | 0.050 |
Why?
|
Contactins | 1 | 2022 | 21 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2020 | 11480 | 0.050 |
Why?
|
Enterococcus faecalis | 1 | 2023 | 247 | 0.050 |
Why?
|
Apoptosis | 1 | 2018 | 9497 | 0.050 |
Why?
|
Glycols | 1 | 2021 | 55 | 0.050 |
Why?
|
Glycolates | 1 | 2021 | 40 | 0.050 |
Why?
|
Ethylene Glycols | 1 | 2022 | 190 | 0.050 |
Why?
|
Galectins | 1 | 2024 | 282 | 0.050 |
Why?
|
Hypersensitivity, Delayed | 1 | 2012 | 490 | 0.050 |
Why?
|
GATA3 Transcription Factor | 1 | 2021 | 152 | 0.050 |
Why?
|
Asthma | 1 | 2019 | 6167 | 0.050 |
Why?
|
Vero Cells | 1 | 2021 | 484 | 0.040 |
Why?
|
Antibodies, Antinuclear | 1 | 2021 | 344 | 0.040 |
Why?
|
Adult | 6 | 2020 | 219847 | 0.040 |
Why?
|
Adoptive Transfer | 1 | 2022 | 825 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2021 | 780 | 0.040 |
Why?
|
Male | 7 | 2020 | 359413 | 0.040 |
Why?
|
Biofilms | 1 | 2023 | 622 | 0.040 |
Why?
|
T-Box Domain Proteins | 1 | 2021 | 469 | 0.040 |
Why?
|
Gold | 1 | 2022 | 485 | 0.040 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2012 | 619 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11902 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17766 | 0.040 |
Why?
|
Seasons | 1 | 2023 | 1523 | 0.040 |
Why?
|
China | 1 | 2023 | 2340 | 0.040 |
Why?
|
Autoantigens | 1 | 2021 | 877 | 0.040 |
Why?
|
Environmental Monitoring | 1 | 2023 | 1441 | 0.040 |
Why?
|
Photosensitizing Agents | 1 | 2021 | 616 | 0.030 |
Why?
|
Antigens | 1 | 2022 | 1447 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2012 | 2220 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2022 | 908 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2020 | 1870 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2023 | 2138 | 0.030 |
Why?
|
Cell Separation | 1 | 2020 | 1720 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3804 | 0.030 |
Why?
|
Lymphocytes | 1 | 2012 | 2612 | 0.030 |
Why?
|
Administration, Oral | 1 | 2012 | 4044 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18134 | 0.030 |
Why?
|
Cell Polarity | 1 | 2015 | 638 | 0.030 |
Why?
|
Particulate Matter | 1 | 2023 | 2558 | 0.020 |
Why?
|
Cell Movement | 1 | 2024 | 5206 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2012 | 5498 | 0.020 |
Why?
|
Stem Cells | 1 | 2023 | 3525 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2716 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15626 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2022 | 22025 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10829 | 0.010 |
Why?
|
Prognosis | 1 | 2024 | 29636 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7400 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10757 | 0.010 |
Why?
|
Risk Assessment | 1 | 2023 | 24086 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 22041 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13505 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15766 | 0.010 |
Why?
|
Middle Aged | 3 | 2019 | 220175 | 0.010 |
Why?
|
Child | 1 | 2019 | 79758 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 87747 | 0.010 |
Why?
|
Aged | 1 | 2018 | 168995 | 0.000 |
Why?
|